高级检索
当前位置: 首页 > 详情页

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Cardiol, Beijing, Peoples R China [2]Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England [3]Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England [4]Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark [5]Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China [6]Chinese Peoples Liberat Army Gen Hosp, Seventh Clin Ctr, Dept Gerontol & Geriatr Med, Beijing, Peoples R China [7]Haidian Hosp, Dept Geriatr Cardiol, Beijing, Peoples R China [8]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China [9]Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gerontol & Geriatr Med, Sch Med, Shanghai, Peoples R China [10]Dalian Med Univ, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China [11]Tianjin Med Univ, Tianjin Inst Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, Hosp 2, Tianjin, Peoples R China [12]Tianjin Med Univ, Tianjin Geriatr Inst, Dept Geriatr, Gen Hosp, Tianjin, Peoples R China [13]Haerbing Med Univ, Dept Cardiol, Affiliated Hosp 1, Haerbing, Peoples R China [14]Hebei Med Univ, Dept Cardiol, Hosp 2, Shijiazhuang, Hebei, Peoples R China [15]Southern Med Univ, Dept Cardiol, Henan Cardiovasc Hosp, Zhengzhou, Henan, Peoples R China [16]Guangzhou Univ Chinese Med, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Peoples R China [17]Nanjing Med Univ, Benq Med Ctr, Dept Cardiol, Nanjing, Peoples R China [18]Longhua Peoples Hosp, Dept Cardiol, Shenzhen, Peoples R China [19]Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England
出处:
ISSN:

关键词: adverse events atrial fibrillation integrated care mobile health

摘要:
BACKGROUND Current management of patients with atrial fibrillation (AF) is limited by low detection of AF, non-adherence to guidelines, and lack of consideration of patients' preferences, thus highlighting the need for a more holistic and integrated approach to AF management. OBJECTIVE The objective of this study was to determine whether a mobile health (mHealth) technology-supported AF integrated management strategy would reduce AF-related adverse events, compared with usual care. METHODS This is a cluster randomized trial of patients with AF older than 18 years of age who were enrolled in 40 cities in China. Recruitment began on June 1, 2018 and follow-up ended on August 16, 2019. Patients with AF were randomized to receive usual care, or integrated care based on a mobile AF Application (mAFA) incorporating the ABC (Atrial Fibrillation Better Care) Pathway: A, Avoid stroke; B, Better symptom management; and C, Cardiovascular and other comorbidity risk reduction. The primary composite outcome was a composite of stroke/thromboembolism, all-cause death, and rehospitalization. Rehospitalization alone was a secondary outcome. Cardiovascular events were assessed using Cox proportional hazard modeling after adjusting for baseline risk. RESULTS There were 1,646 patients allocated to mAFA intervention (mean age, 67.0 years; 38.0% female) with mean follow-up of 262 days, whereas 1,678 patients were allocated to usual care (mean age, 70.0 years; 38.0% female) with mean follow-up of 291 days. Rates of the composite outcome of 'ischemic stroke/systemic thromboembolism, death, and rehospitalization' were lower with the mAFA intervention compared with usual care (1.9% vs. 6.0%; hazard ratio [HR]: 0.39; 95% confidence interval [CI]: 0.22 to 0.67; p < 0.001). Rates of rehospitalization were lower with the mAFA intervention (1.2% vs. 4.5%; HR: 0.32; 95% CI: 0.17 to 0.60; p < 0.001). Subgroup analyses by sex, age, AF type, risk score, and comorbidities demonstrated consistently lower HRs for the composite outcome for patients receiving the mAFA intervention compared with usual care (all p < 0.05). CONCLUSIONS An integrated care approach to holistic AF care, supported by mHealth technology, reduces the risks of rehospitalization and clinical adverse events. (Mobile Health [mHealth] technology integrating atrial fibrillation screening and ABC management approach trial; ChiCTR-OOC-17014138). (C) 2020 by the American College of Cardiology Foundation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
JCR分区:
出版当年[2018]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Cardiol, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Cardiol, Beijing, Peoples R China [2]Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England [3]Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England [4]Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark [*1]Liverpool Ctr Cardiovasc Sci, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England [*2]Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, 28 Fuxin Rd, Beijing 100853, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)